一名服用甲状腺激素替代药物的女性中依托孕烯植入剂失效：病例报告
Etonogestrel implant failure in a woman taking thyroid hormone replacement: A case report.
作者信息
Moylan Alice, Brown Jewel, Chen Melissa J, Creinin Mitchell D
机构信息
University of California, Davis School of Medicine, 4610 X St., Sacramento, CA 95817, USA.
Department of Obstetrics and Gynecology, University of California, Davis Health, 4860 Y Street, Suite 2500, Sacramento, CA 95817, USA.
出版信息
Case Rep Womens Health. 2025 Jan 17;45:e00687. doi: 10.1016/j.crwh.2025.e00687. eCollection 2025 Mar.
Abstract
The etonogestrel implant is known to have high contraceptive efficacy for up to 5 years. This case report describes etonogestrel implant failure during year 4 of use in a patient with a normal body mass index. The patient was receiving thyroid hormone replacement after a thyroidectomy and was found to have iatrogenic thyrotoxicosis in the months preceding pregnancy. Further study of the effects of thyroid hormone on etonogestrel metabolism are indicated.
摘要
已知依托孕烯植入剂在长达5年的时间内具有较高的避孕效果。本病例报告描述了一名体重指数正常的患者在使用依托孕烯植入剂第4年时避孕失败的情况。该患者在甲状腺切除术后接受甲状腺激素替代治疗，在怀孕前几个月被发现患有医源性甲状腺毒症。有必要进一步研究甲状腺激素对依托孕烯代谢的影响。
相似文献
1
Etonogestrel implant failure in a woman taking thyroid hormone replacement: A case report.一名服用甲状腺激素替代药物的女性中依托孕烯植入剂失效：病例报告
Case Rep Womens Health. 2025 Jan 17;45:e00687. doi: 10.1016/j.crwh.2025.e00687. eCollection 2025 Mar.
2
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.依托孕烯植入剂和左炔诺孕酮宫内节育器的长期使用：超出美国食品药品监督管理局批准使用期限两年。
Am J Obstet Gynecol. 2017 Jun;216(6):586.e1-586.e6. doi: 10.1016/j.ajog.2017.01.036. Epub 2017 Jan 29.
3
Etonogestrel contraceptive implant failure in a woman taking rifampin: a case report.一名服用利福平的女性中依托孕烯避孕植入剂失效：病例报告
Contracept Reprod Med. 2022 May 5;7(1):5. doi: 10.1186/s40834-022-00172-1.
4
A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.一项随机试验比较了双剂量与单剂量依托孕烯植入剂克服与依非韦伦为基础的抗逆转录病毒治疗的相互作用。
Am J Obstet Gynecol. 2024 Aug;231(2):242.e1-242.e9. doi: 10.1016/j.ajog.2024.03.001. Epub 2024 Mar 7.
5
The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.卡马西平对使用避孕植入剂的女性体内依托孕烯浓度的影响。
Contraception. 2017 Jun;95(6):571-577. doi: 10.1016/j.contraception.2017.03.004. Epub 2017 Mar 10.
6
Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.避孕埋植剂使用者的个体特征与依伴侬血药浓度的关系。
Contraception. 2019 Jul;100(1):37-41. doi: 10.1016/j.contraception.2019.03.045. Epub 2019 Apr 10.
7
Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.药物流产时立即与延迟植入依托孕烯释放植入剂的随机对照等效性试验
Hum Reprod. 2016 Nov;31(11):2484-2490. doi: 10.1093/humrep/dew238. Epub 2016 Sep 22.
8
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.使用超过美国食品药品监督管理局批准期限的依托孕烯植入剂和左炔诺孕酮宫内节育器。
Obstet Gynecol. 2015 Mar;125(3):599-604. doi: 10.1097/AOG.0000000000000690.
9
Lactogenesis and breastfeeding after immediate vs delayed birth-hospitalization insertion of etonogestrel contraceptive implant: a noninferiority trial.即刻与延迟至产后住院期放置依托孕烯植入剂对产后泌乳和母乳喂养的影响：一项非劣效性试验。
Am J Obstet Gynecol. 2023 Jan;228(1):55.e1-55.e9. doi: 10.1016/j.ajog.2022.08.012. Epub 2022 Aug 12.
10
A life-threatening ectopic pregnancy with etonogestrel implant.带依托孕烯植入剂的危及生命的宫外孕。
Contraception. 2012 Feb;85(2):215-7. doi: 10.1016/j.contraception.2011.07.008. Epub 2011 Sep 13.
本文引用的文献
1
The impact of thyroid diseases starting from birth on reproductive function.从出生开始的甲状腺疾病对生殖功能的影响。
Hormones (Athens). 2019 Dec;18(4):365-381. doi: 10.1007/s42000-019-00156-y. Epub 2019 Nov 16.
2
Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.遗传变异对避孕埋植剂使用者中依托孕烯稳态浓度的影响。
Obstet Gynecol. 2019 Apr;133(4):783-794. doi: 10.1097/AOG.0000000000003189.
3
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.依托孕烯植入剂和左炔诺孕酮宫内节育器的长期使用：超出美国食品药品监督管理局批准使用期限两年。
Am J Obstet Gynecol. 2017 Jun;216(6):586.e1-586.e6. doi: 10.1016/j.ajog.2017.01.036. Epub 2017 Jan 29.
4
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.依托孕烯释放皮下避孕植入剂长达5年的延长使用：与左炔诺孕酮释放皮下植入剂的比较。
Hum Reprod. 2016 Nov;31(11):2491-2498. doi: 10.1093/humrep/dew222. Epub 2016 Sep 26.
5
Hepatic dysfunction in hospitalized patients with acute thyrotoxicosis: a decade of experience.急性甲状腺毒症住院患者的肝功能障碍：十年经验
ISRN Endocrinol. 2012;2012:325092. doi: 10.5402/2012/325092. Epub 2012 Nov 29.
6
Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.甲状腺功能减退症小鼠中 CAR 和 PXR 对细胞色素 P450 表达的相反调节。
Toxicol Appl Pharmacol. 2012 Sep 1;263(2):131-7. doi: 10.1016/j.taap.2012.03.017. Epub 2012 Apr 3.
7
Effect of thyroid hormone on the activity of CYP3A enzyme in humans.甲状腺激素对人体 CYP3A 酶活性的影响。
J Clin Pharmacol. 2010 Jan;50(1):88-93. doi: 10.1177/0091270009344336. Epub 2009 Oct 6.
8
Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.单棒式依托孕烯植入剂（依伴侬）的安全性与有效性：11项国际临床试验结果
Fertil Steril. 2009 May;91(5):1646-53. doi: 10.1016/j.fertnstert.2008.02.140. Epub 2008 Apr 18.
9
Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.依托孕烯植入剂（依伴侬）导致的意外妊娠：来自澳大利亚上市后经验的病例系列
Contraception. 2005 Apr;71(4):306-8. doi: 10.1016/j.contraception.2004.10.005.
Zotero 插件